GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Genes Tech Group Holdings Co Ltd (HKSE:08257) » Definitions » Cash And Cash Equivalents

Genes Tech Group Holdings Co (HKSE:08257) Cash And Cash Equivalents : HK$37.7 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Genes Tech Group Holdings Co Cash And Cash Equivalents?

Genes Tech Group Holdings Co's quarterly cash and cash equivalents declined from Jun. 2023 (HK$26.96 Mil) to Sep. 2023 (HK$0.00 Mil) but then increased from Sep. 2023 (HK$0.00 Mil) to Dec. 2023 (HK$37.67 Mil).

Genes Tech Group Holdings Co's annual cash and cash equivalents increased from Dec. 2021 (HK$48.61 Mil) to Dec. 2022 (HK$60.88 Mil) but then declined from Dec. 2022 (HK$60.88 Mil) to Dec. 2023 (HK$37.67 Mil).


Genes Tech Group Holdings Co Cash And Cash Equivalents Historical Data

The historical data trend for Genes Tech Group Holdings Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genes Tech Group Holdings Co Cash And Cash Equivalents Chart

Genes Tech Group Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.43 26.45 48.61 60.88 37.67

Genes Tech Group Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.88 - 26.96 - 37.67

Genes Tech Group Holdings Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Genes Tech Group Holdings Co  (HKSE:08257) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Genes Tech Group Holdings Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Genes Tech Group Holdings Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Genes Tech Group Holdings Co (HKSE:08257) Business Description

Traded in Other Exchanges
N/A
Address
No. 80, Baotai 3rd Road, Hsinchu County, Zhubei City, TWN, 30244
Genes Tech Group Holdings Co Ltd is engaged in the business of Provision of turnkey solution and Trading of used semiconductor manufacturing equipment and parts. It generates prime revenue from the Provision of turnkey solution segment. The company offers turnkey solution of used SME and Parts to customers who need to alter and upgrade the semiconductors of production systems from time to time. The SME and parts supplied by the group include furnaces, clean tracks, and other related items, which are used at the front-end of the semiconductor manufacturing process, wafer fabrication, such as deposition, photoresist coating, and development. It has a business presence in Taiwan, the PRC, Singapore, the United States, Japan and other countries.

Genes Tech Group Holdings Co (HKSE:08257) Headlines

No Headlines